Antibacterial Drugs Market Review and also Projection (2020 – 2027)

1. Antibacterial Drugs Market Review and also Antibacterial Drugs Market Review and also Projection (2020 – 2027) Projection (2020 – 2027) Antibacterial drugs are majorly used in treatment and prevention of infectious diseases and are categorized into seven major classes based on their molecular structure namely, aminoglycosides, -Lactams, tetracyclines, sulfonamides, quinolones, macrolides, and phenicols. β The global antibacterial drugs market is estimated to account for US$ 42,048.3 Mn value IN 2020 and is expected to reach US$ 44,063.3 Mn US$ 44,063.3 Mn by the end of 2027 US$ 42,048.3 Mn in terms of 2027. Global Antibacterial Drugs Market: Drivers Global Antibacterial Drugs Market: Drivers Increasing prevalence of bacterial infections is expected to propel growth of the global antibacterial drugs market over the forecast period. For instance, according to the study, ‘Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon’, published in May 2019,  the prevalence of bacterial vaginosis was 26.2% in the study population. Request for Sample Report: Request for Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/177 https://www.coherentmarketinsights.com/insight/request-sample/177 Moreover, increasing approval and launch of new antibacterial drugs is also expected to aid in growth of the market. For instance, in November 2019, Shionogi Inc. received the U.S. Food and Drug Administration approval for its Fetroja (cefiderocol), an antibacterial drug for treatment of complicated urinary tract infections in patients 18 years of age or older. -lactams held dominant position in the global antibacterial drugs market in 2019, accounting β for 59.3% 59.3% share in terms of value, followed by Quinolones and Macrolides, respectively. Global Antibacterial Drugs Market: Restraints Global Antibacterial Drugs Market: Restraints Increasing number of multi-drug resistant bacterial strains is expected to hinder growth of the market. Excessive usage of various antibacterial drugs has led to evolution of various multi-drug resistant bacterial strains such as vancomycin-resistant enterococci (VRE), methicillin-resistant

2. Staphylococcus aureus (MRSA), extended-spectrum -lactamase (ESBLs), MDR Escherichia coli, MDR Klebsiella pneumoniae, MDR Acinetobacter baumannii, MDR Pseudomonas aeruginosa, and MDR Enterococcus faecium. β Moreover, failure of current antibiotic discovery model in delivering new agents in order to contain present levels of antibiotic resistance is also expected to limit growth of the market. Global Antibacterial Drugs Market: Opportunities Global Antibacterial Drugs Market: Opportunities    Pharmaceutical companies have failed to deliver significant number of new antibacterial drugs. In the future, companies need to adopt collaboration and partnership strategies for R&D on new antibacterial drugs. Moreover, investment in the R&D of previously characterized lead compounds that did not commercialize is also expected to aid in growth of the market. With improved technology and expertise, the failed candidates can be safe and efficacious antibacterial drugs. The global antibacterial drugs market was valued at US$ 41,780.2 Mn to reach a value of US$ 44,063.3 Mn US$ 44,063.3 Mn by 2027 at a CAGR of 0.7% US$ 41,780.2 Mn in 2019 and is forecast 0.7% between 2020 and 2027. Market Trends/Key Takeaways Market Trends/Key Takeaways Loss of patent and marketing exclusivity of antibacterial drugs has led to generic drug manufacturers introducing their own version of antibacterial drugs in the market. These off- patent molecules have attracted a large number of manufacturers and today account for a sizeable portion of the global antibacterial drugs market. R&D in drug-resistant bacteria is expected to propel growth of the global antibacterial drugs market. For instance, in November 2019, researchers from Northeastern University, Boston, U.S., reported development of a new antibiotic darobactin that selectively eliminates Gram- negative pathogens. Global Antibacterial Drugs Market: Competitive Landscape Global Antibacterial Drugs Market: Competitive Landscape Major players operating in the global antibacterial drugs market include Shionogi Inc, Iterum Therapeutics plc, Kyorin Pharmaceutical Co., Ltd., Allecra Therapeutics GmbH, Wockhardt Ltd., Theravance Biopharma, Inc., R-Pharm Group, Entasis Therapeutics, Melinta Therapeutics, Micurx Pharmaceutical Inc., Debiopharm Group, Boston Pharmaceuticals Inc., TenNor Therapeutics, Sichuan Pharmaceutical Co., Ltd., NacuGen Therapeutics Inc., VenatoRx

3. Pharmaceuticals, Inc., Spero Therapeutics, GlaxoSmithKline plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Forest Laboratories, Inc., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.h Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Antibacterial Drugs Market Research Objective and Assumption • Antibacterial Drugs Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Antibacterial Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Antibacterial Drugs Market, By Regions • Antibacterial Drugs Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Antibacterial Drugs Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Antibacterial Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Antibacterial Drugs Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion To Get Instant Access, Purchase Report Here @ To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/ buy-now/177 buy-now/177 https://www.coherentmarketinsights.com/insight/ Global Antibacterial Drugs Market: Key Developments Global Antibacterial Drugs Market: Key Developments

4. Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, Kyorin Pharmaceutical Co., Ltd. received approval to market the oral quinolone antibacterial drug Lasvic Tablets 75mg, for the treatment of respiratory and ENT infections, from the Ministry of Health, Labor and Welfare, Japan. Major players in the market are also focused on R&D of new antibacterial drugs. For instance, in October 2018, Iterum Therapeutics plc presented data on sulopenem, its novel oral and IV penem antibiotic at IDWeek 2018 in San Francisco, U.S. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com